Last month, the Mesothelioma Applied Research Foundation held this year’s International Symposium on Malignant Mesothelioma in Washington, D.C. Our team of Patient Advocates…
The Mesothelioma Center’s latest webinar on immunotherapy explored how the treatment works, who makes a good candidate and a wealth of other topics. You…
I recently held a webinar for The Mesothelioma Center focused on the differences between chemotherapy and immunotherapy for mesothelioma.The webinar was an excellent…
Asbestos exposure is the primary cause of mesothelioma and asbestosis, devastating conditions that require aggressive treatments. If you become exposed to asbestos, talking with…
On Wednesday, June 15, at 8 p.m. EDT, The Mesothelioma Center at Asbestos.com will host a webinar exclusively for peritoneal mesothelioma patients, their…
Before 2019, the only U.S. Food and Drug Administration-approved treatment for unresectable, locally advanced or metastatic mesothelioma cancer was a single chemotherapy option.
Dr. Rupesh Kotecha is a renowned radiation oncologist in leadership roles at Miami Cancer Institute. He is an associate professor at Florida International University's college of medicine and an adjunct faculty member at Memorial Sloan Kettering.
Fact-checked and verified content:
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
